Table 4.

CEA sensitivity analysis.

One-way sensitivity analysis of base-case analysis	Range	ICER (US$/LY)
CAH incidence	1:10,000	20,972.42
	1:15,000	33,337.73
Clinical recognition SW/SV	16/11%	19,189.90
	55/45%	38,959.02
SW mortality without NBS	11%	17,870.08
	4.2%	46,387.70
False positive rate	0.1%	25,423.64
	0.5%	25,872.61
Cohort of date birth from 2000		36,630.47

CEA, cost-effectiveness analysis; SW, salt-wasting; SV, simple virilizing; LY, years of life saved; NBS, newborn screening.